From Name:
From Email:
To Name:
To Email:

Optional Message:

Novel radiation therapy promising for metastatic castration-resistant prostate cancer

from Reuters Health News via MDLinx

A novel, targeted radiation therapy called Lutetium-177 PSMA-617 has shown promising clinical activity in men with prostate-specific membrane antigen-positive metastatic, castration-resistant prostate cancer that progressed despite multiple standard therapies. "LuPSMA provides a new approach to a form of the disease that has been difficult to treat," said the lead study investigator in a news release. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063